It's the third hypertension drug we've seen recalled in a month, with scientists flagging "global safety concerns" with this ...
For the 12% of adults in the U.S. now taking a weight-loss medication that targets the GLP-1 and/or GIP hormones to restrict appetite or treat diabetes—think Ozempic, Wegovy, Mounjaro, and ...